CClinicalTrials.gg
CompletedNCT03698591Updated Dec 17, 2019Results posted

Testing a Neurocognitive Model of Distancing Using Transcranial Magnetic Stimulation.

An interventional study of Transcranial magnetic stimulation task and Sham transcranial magnetic stimulation task in Emotion Regulation and Real Versus Sham Transcranial Magnetic Stimulation (TMS), sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-12-17.

Sponsored by Duke University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

Distancing oneself from a current distressing situation is a mental skill that can help people to manage their emotions. However, little is known about how distancing works in the brain. Recently developed tools in neuroscience that can modify brain activity might be able to make distancing more or less effective. In doing so, the results could lead to a better understanding of the cognitive processes and neural circuits that support distancing as a form of emotion regulation. If successful, this research may lead to the development of new treatments to help those who suffer from stress-related disorders, such as anxiety and depression.

Read the detailed description

Distancing is an emotion regulation skill that relies in part on self-projection, or the ability to shift perspective from the here and now to a simulated time, place, or person. Based on prior review and meta-analysis of the distancing literature, a new model has been developed of the neurocognitive processes that support distancing. The proposed experiment will test the model causally through a neural intervention that should impair or enhance the ability of healthy adults to successfully apply distancing to down-regulate negative affect. In the model, it is hypothesized that the temporoparietal junction (TPJ) was a key region mediating the self-projection aspect of distancing. Leveraging recent functional magnetic resonance imaging (fMRI) work, the experiment will functionally modulate this region through inhibitory transcranial magnetic stimulation (TMS) to test its causal role in distancing. Importantly, the proposed work shifts emphasis from traditional models of emotion regulation, which implicate frontal executive control mechanisms, to new cognitive processes and brain targets that can ultimately lead to novel approaches to treat affective disorders.

02

Conditions studied

  • Emotion Regulation
  • Real Versus Sham Transcranial Magnetic Stimulation (TMS)
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between 18-39 years inclusive
  • Willing to provide informed consent
  • English speaking
  • Signed HIPAA authorization

Exclusion criteria

Exclusion Criteria:

  • Current or recent (within the past 6 months) substance abuse or dependence, excluding nicotine and caffeine (assessed via urine test).
  • Current serious medical illness (assessed via self report).
  • History of seizure except those therapeutically induced by ECT (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain surgery, head injury, cranial metal implants, known structural brain lesion, devices that may be affected by TMS or MRI (pacemaker, medication pump, cochlear implant, implanted brain stimulator) [assessed via TMS Adult Safety Screening form].
  • Subjects are unable or unwilling to give informed consent.
  • Diagnosed any Axis I Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) disorder (assessed via self report).
  • Subjects with a clinically defined neurological disorder (assessed via self report) including, but not limited to:

    1. Any condition likely to be associated with increased intracranial pressure
    2. Space occupying brain lesion.
    3. History of stroke.
    4. Transient ischemic attack within two years.
    5. Cerebral aneurysm.
    6. Dementia.
    7. Parkinson's disease.
    8. Huntington's disease.
    9. Multiple sclerosis.
  • Increased risk of seizure for any reason, including prior diagnosis of increased intracranial pressure (such as after large infarctions or trauma), or currently taking medication that lowers the seizure threshold (assess via self report).
  • Subjects not willing to tolerate the confinement associated with being in the MRI scanner.
  • Women who are pregnant or breast-feeding (assessed via urine test).
  • Blindness.
  • Inability to read or understand English.
  • Intracranial implants, such as:

    1. Cochlear implants;
    2. Aneurysms clips;
    3. Shunts;
    4. Stimulators;
    5. Electrodes;
    6. Cardiac pacemakers;
    7. Vagus Nerve stimulation devices.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Transcranial magnetic stimulation (TMS), then Sham TMS.

    Experimenters will employ a continuous theta-burst stimulation (cTBS) sequence using a figure-8 coil positioned tangentially to the scalp over the target coordinates. Experimenters have defined the target coordinates for stimulation (Montreal Neuroscience Institute coordinates -53, -53, 23) based on peak objective distancing activation in the left temporal parietal junction (TPJ) in previous fMRI studies using the same task. Thirty minutes after stimulation, experimenters will employ a sham version of the TMS intervention where subjects will receive a small electrical stimulation on the scalp via two small electrodes in conjunction with a TMS coil activation. The TMS coil will be reoriented to stimulate into the air away from the scalp, simulating traditional TMS, without inducing any current to the subject.

    Device: Transcranial magnetic stimulation task

  • Sham comparator
    Sham TMS, then Transcranial magnetic stimulation (TMS)

    Experimenters will employ a sham version of the TMS intervention where subjects will receive a small electrical stimulation on the scalp via two small electrodes in conjunction with a TMS coil activation. The TMS coil will be reoriented to stimulate into the air away from the scalp, simulating traditional TMS, without inducing any current to the subject. Experimenters have defined the target coordinates for the stimulation (Montreal Neuroscience Institute coordinates -53, -53, 23) based on peak objective distancing activation in the left temporal parietal junction (TPJ) in previous fMRI studies using the same task. Thirty minutes post sham stimulation, experimenters will employ a continuous theta-burst stimulation (cTBS) sequence using a figure-8 coil positioned tangentially to the scalp over the target coordinates.

    Device: Sham transcranial magnetic stimulation task

Interventions

  • DeviceTranscranial magnetic stimulation task

    Experimenters will employ a continuous theta-burst stimulation (cTBS) sequence using a figure-8 coil positioned tangentially to the scalp over the target coordinates. Experimenters have defined the target coordinates for stimulation (Montreal Neuroscience Institute coordinates -53, -53, 23) based on peak objective distancing activation in the left temporal parietal junction (TPJ) in previous fMRI studies using the same task.

    Also known as: TMS

  • DeviceSham transcranial magnetic stimulation task

    A sham version of the TMS intervention where subjects will receive a small electrical stimulation on the scalp via two small electrodes in conjunction with a TMS coil activation. The TMS coil will be reoriented to stimulate into the air away from the scalp, simulating traditional TMS, without inducing any current to the subject.

    Also known as: Sham TMS

06

What researchers measure

Primary outcomes

  1. Change in Self-reported Valence (Distancing) From Baseline to 30 Minutes Post Stimulation.

    Valence is how positive or negative a subject feels. Subjects will be asked to rate how they feel on a 7 point Likert scale ranging from 1 (very negative) to 7 (very positive) after using an emotion regulation technique (distancing) when shown graphic stimuli.

    Time frame: baseline, 30 minutes post stimulation

Secondary outcomes

  1. Change in Self-reported Effort (Distancing) From Baseline to 30 Minutes Post Stimulation.

    Effort is how difficult it was for a subject to use a specific emotion regulation technique. Subjects will be asked to rate how much effort they felt they used on a 7 point Likert scale ranging from 1 (very little effort) to 7 (very high effort) after using an emotion regulation technique (distancing) when shown graphic stimuli.

    Time frame: baseline, 30 minutes post stimulation

Other outcomes

  1. Change in Self-reported Valence (Distraction) From Baseline to 30 Minutes Post Stimulation.

    Valence is how positive or negative a subject feels. Subjects will be asked to rate how they feel on a 7 point Likert scale ranging from 1 (very negative) to 7 (very positive) after using an emotion regulation technique (distraction) when shown graphic stimuli.

    Time frame: baseline, 30 minutes post stimulation

  2. Change in Self-reported Effort (Distraction) From Baseline to 30 Minutes Post Stimulation.

    Effort is how difficult is was for a subject to use a specific emotion regulation technique. Subjects will be asked to rate how much effort they felt they used on a 7 point Likert scale ranging from 1 (very little effort) to 7 (very high effort) after using an emotion regulation technique (distraction) when shown graphic stimuli.

    Time frame: baseline, 30 minutes post stimulation

07

Results

Posted Dec 10, 2019

Participant flow

Subjects were recruited from 11/1/18 until 5/17/19. Subjects were recruited and screened from the Duke University Brain Imaging Analysis Center (BIAC) research participant pool as well as from e-flyers on Duke University's electronic community bulletin board (DukeList).

Participant flow — Overall Study
MilestoneTranscranial Magnetic Stimulation (TMS), Then Sham TMSSham TMS, Then Transcranial Magnetic Stimulation (TMS)
Started2020
Completed1515
Not completed55
Withdrew: Withdrawal by subject22
Withdrew: Failed drug screen11
Withdrew: Failed health screen01
Withdrew: Ineligible for financial compensation10
Withdrew: Equipment error10
Withdrew: Could not establish tms dosage01

Outcome measures

PrimaryChange in Self-reported Valence (Distancing) From Baseline to 30 Minutes Post Stimulation.

Valence is how positive or negative a subject feels. Subjects will be asked to rate how they feel on a 7 point Likert scale ranging from 1 (very negative) to 7 (very positive) after using an emotion regulation technique (distancing) when shown graphic stimuli.

Time frame:
baseline, 30 minutes post stimulation
Reported as:
Mean · score on a scale
Change in Self-reported Valence (Distancing) From Baseline to 30 Minutes Post Stimulation.
score on a scaleTranscranial Magnetic Stimulation (TMS)Sham TMS
Change in Self-reported Valence (Distancing) From Baseline to 30 Minutes Post Stimulation..662 ± .565.668 ± .561
Statistical analysis
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .019 (P-value corresponds to 3 way interaction. A priori significance threshold of p \< .05.) · F-statistic: 6.155
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .021 (P-value corresponds to two-way interaction. A priori significance threshold of p \< .05.) · F-statistic: 5.911
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · t-test, 2 sided · p = .108 (A priori significance threshold of p \< .05.) · T-statistic: -1.656
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .948 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: .004
SecondaryChange in Self-reported Effort (Distancing) From Baseline to 30 Minutes Post Stimulation.

Effort is how difficult it was for a subject to use a specific emotion regulation technique. Subjects will be asked to rate how much effort they felt they used on a 7 point Likert scale ranging from 1 (very little effort) to 7 (very high effort) after using an emotion regulation technique (distancing) when shown graphic stimuli.

Time frame:
baseline, 30 minutes post stimulation
Reported as:
Mean · score on a scale
Change in Self-reported Effort (Distancing) From Baseline to 30 Minutes Post Stimulation.
score on a scaleTranscranial Magnetic Stimulation (TMS)Sham TMS
Change in Self-reported Effort (Distancing) From Baseline to 30 Minutes Post Stimulation.3.610 ± .8413.546 ± .959
Statistical analysis
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .862 (P-value corresponds to the two way interaction of task condition and study arm . A priori significance threshold of p \< .05.) · F-statistic: .031
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .054 (P-value corresponds to the main effect of study period. A priori threshold of p \< .05.) · F-statistic: 4.040
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · t-test, 2 sided · p = .012 (A priori significance threshold of p \< .05.) · T-statistic: 2.694
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .085 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: 3.196
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .013 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: 7.162
Other pre-specifiedChange in Self-reported Valence (Distraction) From Baseline to 30 Minutes Post Stimulation.

Valence is how positive or negative a subject feels. Subjects will be asked to rate how they feel on a 7 point Likert scale ranging from 1 (very negative) to 7 (very positive) after using an emotion regulation technique (distraction) when shown graphic stimuli.

Time frame:
baseline, 30 minutes post stimulation
Reported as:
Mean · score on a scale
Change in Self-reported Valence (Distraction) From Baseline to 30 Minutes Post Stimulation.
score on a scaleTranscranial Magnetic Stimulation (TMS)Sham TMS
Change in Self-reported Valence (Distraction) From Baseline to 30 Minutes Post Stimulation..617 ± .608.710 ± .661
Statistical analysis
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .019 (P-value corresponds to 3 way interaction. A priori significance threshold of p \< .05.) · F-statistic: 6.155
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .021 (P-value corresponds to two-way interaction. A priori significance threshold of p \< .05.) · F-statistic: 5.911
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · t-test, 2 sided · p = .210 (A priori significance threshold of p \< .05.) · T-statistic: 1.282
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .948 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: .004
Other pre-specifiedChange in Self-reported Effort (Distraction) From Baseline to 30 Minutes Post Stimulation.

Effort is how difficult is was for a subject to use a specific emotion regulation technique. Subjects will be asked to rate how much effort they felt they used on a 7 point Likert scale ranging from 1 (very little effort) to 7 (very high effort) after using an emotion regulation technique (distraction) when shown graphic stimuli.

Time frame:
baseline, 30 minutes post stimulation
Reported as:
Mean · score on a scale
Change in Self-reported Effort (Distraction) From Baseline to 30 Minutes Post Stimulation.
score on a scaleTranscranial Magnetic Stimulation (TMS)Sham TMS
Change in Self-reported Effort (Distraction) From Baseline to 30 Minutes Post Stimulation.3.620 ± 1.0833.590 ± 1.146
Statistical analysis
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .862 (P-value corresponds to the two way interaction of task condition and study arm . A priori significance threshold of p \< .05.) · F-statistic: .031
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .054 (P-value corresponds to the main effect of study period. A priori threshold of p \< .05.) · F-statistic: 4.040
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · t-test, 2 sided · p = .415 (A priori significance threshold of p \< .05.) · T-statistic: .828
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .085 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: 3.196
  • Transcranial Magnetic Stimulation (TMS) vs Sham TMS · ANOVA · p = .535 (A priori threshold of p \< .05. This value reflects the test of the main effect of study arm.) · F-statistic: .396

Adverse events

Collected over 30 minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Transcranial Magnetic Stimulation (TMS)0/30 (0%)0/30 (0%)0/30 (0%)
Sham TMS0/30 (0%)0/30 (0%)0/30 (0%)

Baseline characteristics

All subjects who completed the study protocol.

Age, Categorical
Age, Categorical(Participants)Transcranial Magnetic Stimulation (TMS), Then Sham TMSSham TMS, Then Transcranial Magnetic StimulationTotal
<=18 years000
Between 18 and 65 years151530
>=65 years000
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Transcranial Magnetic Stimulation (TMS), Then Sham TMSSham TMS, Then Transcranial Magnetic StimulationTotal
Female12820
Male3710
Unknown/unlisted000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Transcranial Magnetic Stimulation (TMS), Then Sham TMSSham TMS, Then Transcranial Magnetic StimulationTotal
Hispanic or Latino112
Not Hispanic or Latino11819
Unknown or Not Reported369
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Transcranial Magnetic Stimulation (TMS), Then Sham TMSSham TMS, Then Transcranial Magnetic StimulationTotal
American Indian or Alaska Native000
Asian8816
Native Hawaiian or Other Pacific Islander000
Black or African American011
White7613
More than one race000
Unknown or Not Reported000
08

Study locations

1 site
  • LaBar Lab, Duke University
    Durham, North Carolina 27708, United States
09

References and documents

Publications

  • Dorfel D, Lamke JP, Hummel F, Wagner U, Erk S, Walter H. Common and differential neural networks of emotion regulation by Detachment, Reinterpretation, Distraction, and Expressive Suppression: a comparative fMRI investigation. Neuroimage. 2014 Nov 1;101:298-309. doi: 10.1016/j.neuroimage.2014.06.051. Epub 2014 Jun 30. PubMed 24993897 ↗
  • Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron. 2005 Jan 20;45(2):201-6. doi: 10.1016/j.neuron.2004.12.033. PubMed 15664172 ↗
  • Madore KP, Thakral PP, Beaty RE, Addis DR, Schacter DL. Neural Mechanisms of Episodic Retrieval Support Divergent Creative Thinking. Cereb Cortex. 2019 Jan 1;29(1):150-166. doi: 10.1093/cercor/bhx312. PubMed 29161358 ↗
  • McRae K, Hughes B, Chopra S, Gabrieli JD, Gross JJ, Ochsner KN. The neural bases of distraction and reappraisal. J Cogn Neurosci. 2010 Feb;22(2):248-62. doi: 10.1162/jocn.2009.21243. PubMed 19400679 ↗
  • Winecoff A, Labar KS, Madden DJ, Cabeza R, Huettel SA. Cognitive and neural contributors to emotion regulation in aging. Soc Cogn Affect Neurosci. 2011 Apr;6(2):165-76. doi: 10.1093/scan/nsq030. Epub 2010 Apr 12. PubMed 20385663 ↗
  • Powers JP, Davis SW, Neacsiu AD, Beynel L, Appelbaum LG, LaBar KS. Examining the Role of Lateral Parietal Cortex in Emotional Distancing Using TMS. Cogn Affect Behav Neurosci. 2020 Oct;20(5):1090-1102. doi: 10.3758/s13415-020-00821-5. PubMed 32839957 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 18, 2018
  • Informed consent form · Oct 29, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — De-identified data relating to the primary and secondary outcomes will be uploaded upon completion of the study.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03698591
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Oct 9, 2018
Start date
Oct 31, 2018
Primary completion
May 24, 2019
Completion
May 24, 2019
Results posted
Dec 10, 2019
Last update
Dec 17, 2019

Study contacts

Kevin S LaBar, PhD
principal investigator · Duke University Faculty

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion